Hellebust T P
Department of Medical Physics, Oslo University Hospital, The Radium Hospital, 0310 Oslo, Norway; Norway and Department of Physics, University of Oslo, Oslo, Norway.
Cancer Radiother. 2018 Jun;22(4):326-333. doi: 10.1016/j.canrad.2018.03.005. Epub 2018 May 30.
Imaging has probably been the most important driving force for the development of brachytherapy treatments the last 20 years. Due to implementation of three-dimensional imaging, brachytherapy is nowadays a highly accurate and reliable treatment option for many cancer patients. To be able to optimize the dose distribution in brachytherapy the anatomy and the applicator(s) or sources should be correctly localised in the images. For computed tomography (CT) the later criteria is easily fulfilled for most brachytherapy sites. However, for many sites, like cervix and prostate, CT is not optimal for delineation since soft tissue is not adequately visualized and the tumor is not well discriminated. For cervical cancer treatment planning based on magnetic resonance imaging (MRI) is recommended. Some centres also use MRI for postimplant dosimetry of permanent prostate seed implant and high dose rate prostate brachytherapy. Moreover, in so called focal brachytherapy where only a part of the prostate is treated, multiparametric MRI is an excellent tool that can assist in defining the target volume. Applicator or source localization is challenging using MRI, but tolls exist to assist this process. Also, geometrical distortions should be corrected or accounted for. Transrectal ultrasound is considered to be the gold standard for high dose rate prostate brachytherapy and transrectal ultrasound -based brachytherapy procedure offers a method for interactive treatment planning. Reconstruction of the needles is sometimes challenging, especially to identify the needle tip. The accuracy of the reconstruction could be improved by measuring the residuals needle length and by using a bi-planar transducer. The last decade several groups worldwide have explored the use of transrectal and transabdominal ultrasound for cervical cancer brachytherapy. Since ultrasonography is widely available, offers fast image acquisition and is a rather inexpensive modality such development is interesting. However, more work is needed to establish this as an adequate alternative for all phases of the treatment planning process. Studies using positron emission tomography imaging in combination with brachytherapy treatment planning are limited. However, development of new tracers may offer new treatment approaches for brachytherapy in the future. Combination of several image modalities will be the optimal solution in many situations, either during the same session or for different fractions. When several image modalities are combined so called image registration procedures are used and it is important to understand the principles and limitations of such procedures.
在过去20年里,成像技术可能一直是近距离放射治疗发展的最重要驱动力。由于三维成像技术的应用,如今近距离放射治疗对于许多癌症患者来说是一种高度精确且可靠的治疗选择。为了能够优化近距离放射治疗中的剂量分布,应在图像中正确定位解剖结构以及施源器或放射源。对于计算机断层扫描(CT),对于大多数近距离放射治疗部位,后一个标准很容易满足。然而,对于许多部位,如子宫颈和前列腺,CT并不适合用于描绘,因为软组织无法得到充分显示,肿瘤也难以很好地辨别。对于宫颈癌治疗计划,建议基于磁共振成像(MRI)。一些中心也将MRI用于永久性前列腺籽源植入和高剂量率前列腺近距离放射治疗的植入后剂量测定。此外,在所谓的聚焦近距离放射治疗中,即仅治疗前列腺的一部分时,多参数MRI是一种出色的工具,可协助确定靶体积。使用MRI进行施源器或放射源定位具有挑战性,但有工具可辅助这一过程。此外,还应校正或考虑几何畸变。经直肠超声被认为是高剂量率前列腺近距离放射治疗的金标准,基于经直肠超声的近距离放射治疗程序提供了一种交互式治疗计划方法。针的重建有时具有挑战性,尤其是识别针尖。通过测量剩余针长度并使用双平面换能器,可以提高重建的准确性。在过去十年中,全球有几个研究小组探索了经直肠和经腹超声在宫颈癌近距离放射治疗中的应用。由于超声检查广泛可用、能快速采集图像且是一种相当廉价的检查方式,这样的发展很有意义。然而,需要做更多工作,以使其成为治疗计划过程所有阶段的合适替代方法。将正电子发射断层扫描成像与近距离放射治疗计划相结合的研究有限。然而,新示踪剂的开发可能会为未来的近距离放射治疗提供新的治疗方法。在许多情况下,无论是在同一次治疗过程中还是针对不同分次,多种成像模式的组合将是最佳解决方案。当组合多种成像模式时,会使用所谓的图像配准程序,理解这些程序的原理和局限性很重要。